This website uses cookies to improve functionality and tailor your browsing experience.
If you continue to use this website, you agree to the placing of cookies on your device.
Please refer to our cookies policy contained in our Privacy Policy for more information.

Rapid Conversion of Evidence Summaries (RaCES) Workshop 13th September 2022

The ARC NWC MIDAS Theme will be holding a RaCES (Rapid Conversion of Evidence Summaries) workshop (in-person) at the next ARCFEST on the 13th September 2022, being held in Kendal.

It will provide an opportunity for people to: learn how to identify and critically evaluate evidence from a systematic review on an important question around policy or practice; assess the implications of the evidence and opportunities for implementing change; and, write a two-page summary for submission for publication. Support will be provided throughout the process by the MIDAS team. For a brief introduction to RaCES see and

If you are interested in joining us, please email the MIDAS team (, letting us know the area of health or social care practice or policy (i.e. your research question) you would like to look at. We are particularly interested in working with groups of 3 to 5 people, whether health and social care professionals or public advisors. Places are limited for this 1 day workshop, so please contact us as soon as possible (closing date 19th August 2022).

This Rapid Conversion of Evidence Summaries (RaCES) explores risk factors for mortality in patients hospitalised with COVID-19.
Previous reviews focussed on the severity of COVID-19 or specific comorbidities. This RaCES evaluates and summarises a systematic review that re-examined the evidence to comprehensively clarify predictors of mortality in hospitalised COVID-19 patients.
Implications for practice and research:
•A quarter of patients hospitalised with COVID-19 subsequently died and a significant proportion of these patients were men and older adults.
•The three most prevalent comorbidities among hospitalised patients were hypertension (43.6%), diabetes (23.8%) and coronary heart disease/cardiovascular disease (12.4%).
•The odds of dying were 2.5 times more if hypertension was present, two times more for diabetes and 3.8 times more for coronary heart disease/cardiovascular disease.
•The most prevalent clinical symptoms reported across all patients were: fever (88%), fatigue (44.5%) and myalgia (21.1%). Fatigue was the only clinical symptom that had a clear association with mortality.
Harrison J, Hill J, Palmer K. Identifying risk factors for mortality in patients admitted to hospital with COVID-19, British Journal of Cardiac Nursing. 2021;16(6):1-4

Making our work, work for you!
The Public Involvement and Engagement sub-group, which is one of the ARC NWC’s Methodological Innovation, Development, Adaptation and Support (MIDAS) theme’s sub-groups, has conducted a scoping exercise to make sure their work and focus was of meaning to researchers, clinicians and members of the public across the region. This short report describes the scoping exercise and the key findings – we hope it is of interest to all those working in health research! Any queries please contact us via